P-127: Patients with Multiple Myeloma on treatment with Anti-CD38 or Anti-BCMA agents have a suboptimal humoral response following COVID-19 vaccination — Evangelos Terpos (2021) | RDL Network
P-127: Patients with Multiple Myeloma on treatment with Anti-CD38 or Anti-BCMA agents have a suboptimal humoral response following COVID-19 vaccination
Ioannis Ntanasis‐Stathopoulos, Vangelis Karalis, Maria Gavriatopoulou, Aimilia D. Sklirou, Panagiotis Malandrakis, Magdalini Migkou, Μαρία Ρούσσου, Despina Fotiou, Harry Alexopoulos, Evangelos Eleutherakis‐Papaiakovou, Foteini Theodorakakou, Efstathios Kastritis, Ioannis P. Trougakos, Meletios A Dimopoulos, Evangelos Terpos
Ioannis Ntanasis‐Stathopoulos, Vangelis Karalis, Maria Gavriatopoulou, Panagiotis Malandrakis, Aimilia D. Sklirou, Evangelos Eleutherakis‐Papaiakovou, Magdalini Migkou, Μαρία Ρούσσου, Despina Fotiou, Harry Alexopoulos, Foteini Theodorakakou, Efstathios Kastritis, Vassiliki A. Iconomidou, Ioannis P. Trougakos, Meletios A Dimopoulos, Evangelos Terpos
Discussion(0)
No comments yet. Be the first to comment.